Abnormal Activation and Connection in Middle Frontal Gyrus: A Potential Imaging Feature for Facial Synkinesis Comorbid Depression

中额回异常激活和连接:面部联带运动合并抑郁症的潜在影像学特征

阅读:1

Abstract

Patients with facial synkinesis (FS) comorbid depression may experience aggravated symptoms of perceived synkinesis and poorer recovery outcomes. Exploring imaging features associated with depressive symptoms could help us better understand disease conditions and formulate appropriate rehabilitation plans. Although abnormal activation in the middle frontal gyrus (MFG) has been reported in depression patients, whether it represents an imaging correlate of depressive symptoms in patients with FS is still unknown. Therefore, a total of 52 participants (20 normal controls [NCs], 32 patients) with both task and resting-state functional magnetic resonance imaging (rs-fMRI) data were included in this study. Comorbid depression was assessed with the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-V), and depressive symptom severity was measured with the Beck Depression Inventory-II (BDI-II). We investigated brain activation during motor tasks (smiling, blinking, and grinning). In addition, the seed-based functional connectivity (FC) between the MFG and other brain areas was calculated in the resting state. Additionally, we analyzed the associations between brain activity and clinical scale scores. The results revealed reduced activation in the sensorimotor and MFG during affected side movements across all tasks (voxel-level p < 0.05, cluster-level p < 0.05, Gaussian random field [GRF]-corrected). Moreover, seed-based FC between the MFG and emotion-related areas was increased (voxel-level p < 0.05, cluster-level p < 0.05, GRF-corrected), indicating impaired emotional networks in patients. Scores on the BDI-II were negatively associated with MFG activation during tasks (R = -0.318, p = 0.027) and positively associated with the FC of the MFG (R = 0.387, p = 0.029). Thus, the MFG activation and connectivity may represent an increased risk for elevated depressive symptoms in patients with FS, warranting further validation in future studies. Trial Registration: Chinese Clinical Trial Registry: ChiCTR1800014630.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。